Newswise — [FORT WASHINGTON, PA — September 7, 2017] The National Comprehensive Cancer Network® (NCCN®) is collaborating with MEDITECH to integrate the NCCN Chemotherapy Order Templates (NCCN Templates®) into MEDITECH’s Web Electronic Health Record (EHR) as standard cancer treatment protocols for use at point of care.
“NCCN’s collaboration with MEDITECH further ensures that practitioners have access to timely, unbiased clinical treatment protocols at the point of care so they can provide patients with the most appropriate regimens for their diagnosis,” said Robert W. Carlson, MD, Chief Executive Officer, NCCN.
As part of the integration, MEDITECH’s Web EHR will provide clinicians direct access to the NCCN Templates and will link to NCCN.org and the corresponding NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®).
“MEDITECH’s collaboration with NCCN is a major part of the company’s strategy to help clinicians streamline oncology care to better treat their patients,” says Hoda Sayed-Friel, Executive Vice President of Strategy, MEDITECH. “We’re thrilled to be including these regimens into our standard content to enhance patient safety and help guide clinicians’ cancer treatment efforts by providing up-to-date, evidence-based standard protocols and best practices within MEDITECH’s Oncology Management solution.”
The information contained in the NCCN Templates enhances patient safety by empowering health care providers to standardize patient care, reduce medical errors, and anticipate and manage adverse events.
NCCN continues to expand its library of chemotherapy order templates to work toward improved safe and effective use of drugs and biologics in cancer care.
For more information about NCCN Templates, visit NCCN.org/templates.
Healthcare is long overdue for genuine disruption and innovation. MEDITECH is helping care organizations to reclaim their productivity, coordinate care, and do more for patients with its mobile Web Electronic Health Record (EHR). With 2,400+ customers, across 22 different countries, MEDITECH solutions are empowering users to provide higher quality care, with greater efficiency, to more people, at a lower cost. A leading EHR vendor with over 45 years of experience, MEDITECH is helping care organizations reach their clinical, analytical, and financial goals. For more information on how MEDITECH is transforming healthcare and building the next generation of EHR leaders, go to ehr.meditech.com.
About the National Comprehensive Cancer Network
The National Comprehensive Cancer Network® (NCCN®), a not-for-profit alliance of 27 leading cancer centers devoted to patient care, research, and education, is dedicated to improving the quality, effectiveness, and efficiency of cancer care so that patients can live better lives. Through the leadership and expertise of clinical professionals at NCCN Member Institutions, NCCN develops resources that present valuable information to the numerous stakeholders in the health care delivery system. As the arbiter of high-quality cancer care, NCCN promotes the importance of continuous quality improvement and recognizes the significance of creating clinical practice guidelines appropriate for use by patients, clinicians, and other health care decision-makers.
The NCCN Member Institutions are: Fred & Pamela Buffett Cancer Center, Omaha, NE; Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute, Cleveland, OH; City of Hope Comprehensive Cancer Center, Los Angeles, CA; Dana-Farber/Brigham and Women’s Cancer Center | Massachusetts General Hospital Cancer Center, Boston, MA; Duke Cancer Institute, Durham, NC; Fox Chase Cancer Center, Philadelphia, PA; Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT; Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance, Seattle, WA; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD; Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL; Mayo Clinic Cancer Center, Phoenix/Scottsdale, AZ, Jacksonville, FL, and Rochester, MN; Memorial Sloan Kettering Cancer Center, New York, NY; Moffitt Cancer Center, Tampa, FL; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute, Columbus, OH; Roswell Park Cancer Institute, Buffalo, NY; Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine, St. Louis, MO; St. Jude Children’s Research Hospital/The University of Tennessee Health Science Center, Memphis, TN; Stanford Cancer Institute, Stanford, CA; University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, AL; UC San Diego Moores Cancer Center, La Jolla, CA; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; University of Colorado Cancer Center, Aurora, CO; University of Michigan Comprehensive Cancer Center, Ann Arbor, MI; The University of Texas MD Anderson Cancer Center, Houston, TX; University of Wisconsin Carbone Cancer Center, Madison, WI; Vanderbilt-Ingram Cancer Center, Nashville, TN; and Yale Cancer Center/Smilow Cancer Hospital, New Haven, CT.